| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 32,681 | 31,287 | 31,704 | 35,874 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 31,287 | 31,704 | 35,874 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 27,097 | 41,137 | 26,650 | 23,217 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 492 | 495 | 508 | 531 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,339) | (10,345) | 4,546 | 12,126 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,092 | (10,345) | 4,546 | 12,126 | | Interest Expense | 2,473 | 2,478 | 2,480 | 2,603 | | Income Before Tax | 2,619 | (12,823) | 2,066 | 9,523 | | Income Tax Expense | 936 | (4,492) | 710 | 3,135 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,683 | (8,331) | 1,356 | 6,388 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,683 | (8,331) | 1,356 | 6,388 | | Preferred Stock And Other Adjustments | (2,579) | (2,578) | (2,578) | (2,578) | | | Net Income Applicable To Common Shares | ($896) | ($10,909) | ($1,222) | $3,810 |
|
1.00% Nasdaq 
Income Statement
